- Specialty healthcare firm Endo International (NASDAQ:ENDP) says it's entering into a program to buy back up to $250M in its common stock.
- The moves will start Monday and it will repurchase shares as soon as practicable thereafter, it says, though it expects to wrap up the purchases by the end of 2015. The plans come as part of a previously authorized $2.5B plan.
- Endo, which finished today up 7% after exercising an option for new indications on XIAFLEX with its partner BioSpecifics Technologies, is up another 0.6% after hours.